Literature DB >> 8030260

Molecular analysis of coxsackievirus A16 reveals a new genetic group of enteroviruses.

T Pöyry1, T Hyypiä, C Horsnell, L Kinnunen, T Hovi, G Stanway.   

Abstract

Coxsackievirus A16 (CAV16) a member of the Enterovirus genus of Picornaviridae, is associated with hand-foot-and-mouth disease, a febrile papulovesicular rash of childhood. We have determined the complete nucleotide sequence of the genome of the prototype strain of CAV16 which consists of 7413 nucleotides plus the poly(A) tail. Alignment of the sequence with the previously studied enteroviruses showed that the genome organization is typical for a member of this virus genus. However, the predicted amino acid sequence of individual CAV16 proteins differed from those of all previously sequenced enteroviruses by 25-62%. The genomic sequence of CAV2 in the capsid and 2A polypeptide regions was also determined. It was found to differ from that of CAV16 by no more than 5-43%. The partial nucleotide sequence of enterovirus 71 in the VP1-2A region suggested that it is also closely related to CAV16. The results indicate that CAV16, CAV2, and enterovirus 71 represent a distinct genetic group of enteroviruses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8030260     DOI: 10.1006/viro.1994.1423

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  29 in total

1.  Molecular identification of enterovirus by analyzing a partial VP1 genomic region with different methods.

Authors:  G Palacios; I Casas; A Tenorio; C Freire
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

2.  Characterization of the recognition site and diagnostic potential of an enterovirus group-reactive monoclonal antibody.

Authors:  A Samuelson; M Forsgren; M Sällberg
Journal:  Clin Diagn Lab Immunol       Date:  1995-05

3.  Sequence analysis of echoviruses in a major antigenic region eliciting enteroviral cross-reactive antibodies.

Authors:  A Samuelson; B Johansson; M Forsgren
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

4.  The immunogenicity and protection effect of the BPL-inactivated CA16 vaccine in different animal systems.

Authors:  Wen Qi An; Zhi Guo Su; Ruo Wen Pan; Bao Ping Yang; Yong Chao Zhang; Liang Shi; Qing Li
Journal:  Hum Vaccin Immunother       Date:  2014-01-08       Impact factor: 3.452

5.  Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification.

Authors:  M S Oberste; K Maher; D R Kilpatrick; M A Pallansch
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

Review 6.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

7.  Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy.

Authors:  D R Kilpatrick; B Nottay; C F Yang; S J Yang; M N Mulders; B P Holloway; M A Pallansch; O M Kew
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

8.  An RNA tertiary structure in the 3' untranslated region of enteroviruses is necessary for efficient replication.

Authors:  M H Mirmomeni; P J Hughes; G Stanway
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

9.  Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China.

Authors:  Linlin Li; Yaqing He; Hong Yang; Junping Zhu; Xingye Xu; Jie Dong; Yafang Zhu; Qi Jin
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

Review 10.  Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes.

Authors:  Mary Jane Cardosa; David Perera; Betty A Brown; Doosung Cheon; Hung Ming Chan; Kwai Peng Chan; Haewol Cho; Peter McMinn
Journal:  Emerg Infect Dis       Date:  2003-04       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.